These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16864711

  • 1. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [Abstract] [Full Text] [Related]

  • 2. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 3. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
    Rudnick DA, Perlmutter DH.
    Hepatology; 2005 Sep; 42(3):514-21. PubMed ID: 16044402
    [Abstract] [Full Text] [Related]

  • 4. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA, Shikapwashya O, Blomenkamp K, Teckman JH.
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [Abstract] [Full Text] [Related]

  • 5. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, Sorge JA.
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [Abstract] [Full Text] [Related]

  • 6. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH.
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [Abstract] [Full Text] [Related]

  • 7. Alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Semin Liver Dis; 1998 Mar; 18(3):217-25. PubMed ID: 9773422
    [Abstract] [Full Text] [Related]

  • 8. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P, Santorelli FM, Saccani S, Bonetti MF, Medicina D, Coni P, Faa G, Callea F.
    Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.
    Teckman JH, An JK, Blomenkamp K, Schmidt B, Perlmutter D.
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G851-62. PubMed ID: 14684378
    [Abstract] [Full Text] [Related]

  • 10. Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.
    Kok KF, Wahab PJ, Houwen RH, Drenth JP, de Man RA, van Hoek B, Meijer JW, Willekens FL, de Vries RA.
    Neth J Med; 2007 May; 65(5):160-6. PubMed ID: 17519511
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, Shah NN, Haq E, Teckman J, Fazili KM.
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [Abstract] [Full Text] [Related]

  • 12. Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Cell Death Differ; 2009 Jan; 16(1):39-45. PubMed ID: 18617899
    [Abstract] [Full Text] [Related]

  • 13. The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins.
    Perlmutter DH.
    Autophagy; 2006 Jan; 2(4):258-63. PubMed ID: 16874089
    [Abstract] [Full Text] [Related]

  • 14. Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.
    Khan Z, Yokota S, Ono Y, Bell AW, Oertel M, Stolz DB, Michalopoulos GK.
    Gene Expr; 2017 Feb 10; 17(2):115-127. PubMed ID: 27938510
    [Abstract] [Full Text] [Related]

  • 15. [Alpha 1-antitrypsin deficiency and the liver (author's transl)].
    Spech HJ, Liehr H.
    Z Gastroenterol; 1982 Jul 10; 20(7):393-404. PubMed ID: 6287750
    [Abstract] [Full Text] [Related]

  • 16. Alpha-1-antitrypsin deficiency and liver disease.
    Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W.
    Dig Dis; 1994 Jul 10; 12(3):139-49. PubMed ID: 7988061
    [Abstract] [Full Text] [Related]

  • 17. Alpha-1-antitrypsin deficiency: diagnosis and treatment.
    Perlmutter DH.
    Clin Liver Dis; 2004 Nov 10; 8(4):839-59, viii-ix. PubMed ID: 15464658
    [Abstract] [Full Text] [Related]

  • 18. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ, Meijer JW, van den Elshout FJ, de Vries RA.
    Ned Tijdschr Geneeskd; 2000 Nov 18; 144(47):2269-72. PubMed ID: 11109473
    [Abstract] [Full Text] [Related]

  • 19. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW.
    Hepatology; 1994 Feb 18; 19(2):538-9. PubMed ID: 8294111
    [No Abstract] [Full Text] [Related]

  • 20. Liver disease in alpha 1-antitrypsin deficiency: a review.
    Fairbanks KD, Tavill AS.
    Am J Gastroenterol; 2008 Aug 18; 103(8):2136-41; quiz 2142. PubMed ID: 18796107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.